PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Pharmacokinetic study on hirsutine and hirsuteine in rats using UPLC–MS/MS

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
An ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method was established to determine hirsutine and hirsuteine in rat plasma. Pharmacokinetics of hirsutine and hirsuteine in rats after intravenous or oral administration has been investigated using this developed UPLC–MS/MS method, and bioavailability of the two drugs was calculated. Diazepam was used as internal standard, and UPLC BEH column (2.1 mm × 50 mm, 1.7 μm) was used at temperature of 40 °C. The mobile phase was composed of acetonitrile and water (containing 0.1% formic acid) at a gradient elution flow rate of 0.4 mL/min. Nitrogen was used as desolvation gas (800 L/h) and conical gas (50 L/h). The multiple reaction monitoring (MRM) model was applied to quantitatively analyze hirsutine m/z 369 → 226, hirsuteine m/z 367 → 169.9, and diazepam (internal standard) m/z 285.1 → 193.3. Rat plasma samples were deproteinized using acetonitrile prior to UPLC–MS/MS analysis. Within the concentration range of 1–200 ng/mL, the linearity of hirsutine and hirsuteine in plasma was good (r > 0.995), and the lower limit of quantitation was 1 ng/mL. Relative standard deviations of intra-day precision for hirsutine and hirsuteine were ≤6.1% and ≤5.9%, respectively, and those of inter-day precision were ≤6% and ≤7.7%. Accuracy for hirsutine and hirsuteine ranged between 92.3% and 104.8%. Bioavailability of hirsutine and hirsuteine was 4.4% and 8.2%, respectively. The method is sensitive and fast with good selectivity and was successfully applied in the pharmacokinetic studies after intravenous and oral administration of hirsutine and hirsuteine.
Rocznik
Strony
99--104
Opis fizyczny
Bibliogr. 37 poz., rys., tab.
Twórcy
autor
  • Department of Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
autor
  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
autor
  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
autor
  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
autor
  • Department of Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
autor
  • Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
autor
  • Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
Bibliografia
  • [1] Ndagijimana, A.; Wang, X. M.; Pan, G. X.; Zhang, F.; Feng, H.; Olaleye, O. Fitoterapia 2013, 86, 35–47.
  • [2] Zhang, J. G.; Geng, C. A.; Huang, X. Y.; Chen, X. L.; Ma, Y. B.; Zhang, X. M.; Chen, J. J. Eur. J. Mass Spectrom. 2017, 23, 11–21.
  • [3] Li, Y. L.; Yang, W. Q.; Zhu, Q. J.; Yang, J. G.; Wang, Z. BioSci. Trends 2015, 9, 237–244.
  • [4] Qi, W.; Yue, S. J.; Sun, J. H.; Simpkins, J. W.; Zhang, L.; Yuan, D. J. Asian Nat. Prod. Res. 2014, 16, 876–883.
  • [5] Ho, T. Y.; Tang, N. Y.; Hsiang, C. Y.; Hsieh, C. L. Phytomedicine 2014, 21, 893–900.
  • [6] Tang, N. Y.; Lin, Y. W.; Ho, T. Y.; Cheng, C. Y.; Chen, C. H.; Hsieh, C. L. Evidence-Based Complementary Altern. Med. 2017, 2017, 9732854.
  • [7] Hsu, H. C.; Tang, N. Y.; Liu, C. H.; Hsieh, C. L. Evidence-Based Complementary Altern. Med. 2013.
  • [8] Pan, H. Q.; Yang, W. Z.; Zhang, Y. B.; Yang, M.; Feng, R. H.; Wu, W. Y.; Guo, D. A. Anal. Bioanal. Chem. 2015, 407, 6057–6070.
  • [9] Lu, W.; Yang, F.; Wang, S. Acta Chromatogr. 2012, 24 643–651.
  • [10] Li, S. P.; Cheng, X. M.; Wang, C. H. J. Ethnopharmacol. 2017, 203, 127–162.
  • [11] Cheng, H. S.; Ton, S. H.; Kadir, K. A. Phytochem. Rev. 2017, 16, 159–193.
  • [12] Wang, X.; Zheng, M.; Liu, J.; Qiao, Z.; Liu, W.; Feng, F. Xenobiotica 2017, 47, 479–487.
  • [13] Ge, Z.; Xie, Y.; Liang, Q.; Wang, Y.; Luo, G. Evid. Based Complement. Alternat. Med. 2014, 2014, 167253.
  • [14] Cai, J.; Lin, C.; Ma, J.; Hu, L.; Lin, G.; Wang, X. J. Chromatogr. Sci. 2014, 52, 661–665.
  • [15] Wu, Y. T.; Lin, L. C.; Tsai, T. H. Biomed. Chromatogr. 2014, 28, 439–445.
  • [16] Kushida, H.; Fukutake, M.; Tabuchi, M.; Katsuhara, T.; Nishimura, H.; Ikarashi, Y.; Kanitani, M.; Kase, Y. Biomed. Chromatogr. 2013, 27, 1647–1656.
  • [17] Wang, X.; Zheng, M.; Liu, J.; Huang, Z.; Bai, Y.; Ren, Z.; Wang, Z.; Tian, Y.; Qiao, Z.; Liu, W.; Feng, F. J. Ethnopharmacol. 2017, 209, 175–183.
  • [18] Zhao, L.; Zang, B.; Qi, W.; Chen, F.; Wang, H.; Kano, Y.; Yuan, D. Fitoterapia 2016, 111, 49–57.
  • [19] Gai, Y.; Chen, H.; Liu, W.; Feng, F.; Xie, N. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 972, 22–28.
  • [20] Wang, W.; Luo, S.; Chen, Y.; Li, B.; Hattori, M. Anal. Sci. 2016, 32, 705–707.
  • [21] Ma, J.; Cai, J.; Lin, G.; Chen, H.; Wang, X.; Wang, X.; Hu, L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 959, 10–15.
  • [22] Liu, M.; Su, X.; Li, G.; Zhao, G.; Zhao, L. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2015, 1006, 8–15.
  • [23] Ai, Y.; Wu, Y.; Wang, F.; Ma, W.; Bian, Q.; Lee, D. Y.; Dai, R. J. Mass Spectrom. 2015, 50, 567–577.
  • [24] Health, U.D.o.; F. Human services; C.f.D.E. Drug Administration; C.f.V.m. Research Fed. Regist. 2001, 66, 206–207.
  • [25] Fang, B.; Bao, S.; Wang, S.; Chen, M.; Chen, B.; Su, K.; Wen, C.; Zhou, Y.; Wang, X.; Jin, Y. Biomed. Chromatogr. 2017, 31.
  • [26] Wang, J.; Zhao, T.; Kong, J.; Peng, H.; Lv, P.; Li, J.; Cao, X.; Zhang, S. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2017, 1061–1062, 270–274.
  • [27] Jiang, Y.; Zhou, H.; Su, K.; Xu, M. Z.; Chen, B. B.; Chen, D. X.; Wen, C. C.; Wu, B.; Luo, X. H.; Wang, X. Q. Lat. Am. J. Pharm. 2016, 35, 2261–2266.
  • [28] Cai, J. Z.; Huang, Z. Z.; Chen, X. L.; Xu, R. A.; He, H. Z.; Lin, C. L.; Lin, G. Y.; Wang, X. Q. Lat. Am. J. Pharm. 2012, 31, 388–393.
  • [29] Bao, S. H.; Geng, P. W.; Yang, S. P.; Liu, Z. Z.; Lin, Y. Y.; Ma, J. S.; Wen, C. C.; Lin, G. Y.; Zou, R. M. Int. J. Clin. Exp. Med. 2016, 9, 6309–6315.
  • [30] Lin, G. Y.; Ma, J. S.; Lin, C. L.; Hu, L. F.; Wang, X. Q. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 2506–2514.
  • [31] Zhang, Q.; Wen, C.; Xiang, Z.; Ma, J.; Wang, X. J. Pharm. Biomed. Anal. 2014, 90, 134–138.
  • [32] Ye, W.; Chen, R.; Sun, W.; Huang, C.; Lin, X.; Dong, Y.; Wen, C.; Wang, X. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2017, 1060, 144–149.
  • [33] Gullick, D. R.; Mott, K. B.; Bartlett, M. G. Biomed. Chromatogr. 2016, 30, 772–789.
  • [34] Yang, X. K.; Ma, Y. J.; Li, N.; Cai, H. J.; Bartlett, M. G. Anal. Chem. 2017, 89, 813–821.
  • [35] Wang, S. H.; Wu, H. Y.; Huang, X. L.; Geng, P. W.; Wen, C. C.; Ma, J. S.; Zhou, Y. F.; Wang, X. Q. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2015, 990, 118–124.
  • [36] Ma, J. S.; Wang, S. H.; Huang, X. L.; Geng, P. W.; Wen, C. C.; Zhou, Y. F.; Yu, L. S.; Wang, X. Q. J. Pharm. Biomed. Anal. 2015, 111, 131–137.
  • [37] Wen, C.; Zhang, Q.; He, Y.; Deng, M.; Wang, X.; Ma, J. Acta Chromatogr. 2015, 27, 81–91.
Uwagi
PL
Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2019).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-3d2aff93-0d0b-4f86-851a-26ed91ac6a41
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.